1.
Fang Y. Advances in the Clinical Application of Novel PCSK9 Inhibitors for High-Risk Atherosclerotic Cardiovascular Disease. IJBLS [Internet]. 2026 Aug. 27 [cited 2026 Nov. 22];16(1):15-2. Available from: https://drpress.org/ojs/index.php/ijbls/article/view/35666